HSKA Share Price

Open 81.28 Change Price %
High 82.43 1 Day 0.56 0.69
Low 81.07 1 Week -0.46 -0.56
Close 81.94 1 Month 1.99 2.49
Volume 109112 1 Year 49.27 150.81
52 Week High 87.33
52 Week Low 26.25
HSKA Important Levels
Resistance 2 83.20
Resistance 1 82.68
Pivot 81.81
Support 1 81.20
Support 2 80.68
NASDAQ USA Most Active Stocks
SPWR 8.98 1.01%
TFSL 17.20 0.17%
RIGL 2.52 9.57%
ADP 102.70 -0.29%
ADP 102.70 -0.29%
ADP 102.70 -0.29%
ADP 102.70 -0.29%
FNFG 10.18 -0.20%
REGN 373.05 3.34%
DELL 13.86 0.22%
More..
NASDAQ USA Top Gainers Stocks
TEAR 5.74 983.02%
CGEI 0.37 85.00%
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
IMGN 3.28 21.03%
VOXX 5.05 20.24%
HAUP 0.06 20.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Heska Corporation (NASDAQ: HSKA)

HSKA Technical Analysis 5
As on 27th Feb 2017 HSKA Share Price closed @ 81.94 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 52.93 & Strong Buy for SHORT-TERM with Stoploss of 76.53 we also expect STOCK to react on Following IMPORTANT LEVELS.
HSKA Target for February
1st Target up-side 85.41
2nd Target up-side 89.47
3rd Target up-side 93.53
1st Target down-side 73.83
2nd Target down-side 69.77
3rd Target down-side 65.71
HSKA Other Details
Segment EQ
Market Capital 44654696.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.heska.com
HSKA Address
HSKA
3760 Rocky Mountain Avenue
Loveland, CO 80538
United States
Phone: 970-493-7272
Fax: 970-619-3003
HSKA Latest News
Interactive Technical Analysis Chart Heska Corporation ( HSKA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Heska Corporation
HSKA Business Profile
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, vaccines and pharmaceuticals, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals and fish. In February 2013, it announced the acquisition of 54.6% interest of Cuattro Veterinary USA, LLC.